Navigation Links
Pfenex Reports Second Quarter 2014 Results and Provides Business Update
Date:8/29/2014

;Pfenex, Inc.Condensed Statement of Operations(in thousands, except per share data)(Unaudited)Three Months EndedJune 30,Six Months EndedJune 30, 2014201320142013Revenue$
3,266
$
2,309
$
5,824
$
5,694
Cost of revenue2,5441,3064,4523,335Gross Profit7221,0031,3722,359Operating expenses:Selling, general and administrative2,0241,6763,5193,459Research and development8601,2721,5382,052Total operating expenses2,8842,9485,0575,511Loss from operations(2,162)(1,945)(3,685)(3,152)Other expense, net(21)(9)(39)(10)Net loss before income taxes(2,183)(1,954)(3,724)(3,162)Income tax benefit (expense)-777
'/>"/>
SOURCE Pfenex Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
2. Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of its Anthrax Vaccine
3. Pfenex Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine
4. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
5. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
6. Interleukin Genetics Reports Third Quarter 2011 Financial Results
7. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
8. Nile Therapeutics Reports 2011 Third Quarter Financial Results
9. Pharmasset Reports Fiscal Year End 2011 Financial Results
10. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
11. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... LONDON , May 1, 2015 ... world market for antithrombotic drugs will reach $22.4bn in ... Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 ... purpose of that investigation is to provide forecasts and ... a business information publisher and consultancy in ...
(Date:5/1/2015)... , May 1, 2015 Albany Molecular ... William S. Marth , AMRI,s President and Chief ... Merrill Lynch 2015 Health Care Conference on Wednesday, May ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:5/1/2015)... and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Roger Jeffs , Ph.D., ... an overview and update on the company,s business at the ... Boston, Massachusetts . The presentation ... PM Eastern Time, and can be accessed via a live ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2
... 2011 Bio-Research Products announced today that it is adding ... its product line. The new Glutathione Reductase offers customers a ... liquid (#801) GR enzyme. Both versions are free of ammonium ... IU/mg protein and an enzyme activity of 300 IU/mL. ...
... Inc. (OTCBB: UGNE), a leader in ... announced that Ashleigh Palmer, President and Chief Executive Officer, ... Annual Oppenheimer Healthcare Conference being held in New York ... 4:10 p.m. ET on Tuesday, December 13, 2011. ...
...  Coronado Biosciences, Inc., (OTCBB: CNDO), a biopharmaceutical company ... for the treatment of autoimmune diseases and cancer, ... the Company,s President, Chief Executive Officer and Director, ... Conference on Wednesday, December 14, 2011 at 10:30 ...
Cached Biology Technology:Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011 2Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference 2
(Date:4/13/2015)... April 13, 2015  higi, a leading cloud-based consumer ... more fully engage with their communities around health and ... protected and secure API.  ... most accessible, affordable, and convenient vehicle to receive validated ... The API will allow higi,s trusted ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... essential nutrient and a pollutant, a byproduct of fossil ... benefit and a hazard, depending on form, location, and ... around the planet, say sixteen scientists in the latest ... "Excess Nitrogen in the U.S. Environment: Trends, Risks, and ...
... simple experiment, University of Illinois chemists have debunked a ... by chemistry professor and Howard Hughes Medical Institute early ... top drug for treating systemic fungal infections works by ... physiology, a finding that could change the direction of ...
... sex of a fetus until after 30 weeks of pregnancy ... groups in Canada and the United States, states an editorial ... Female feticide that is, choosing to abort female ... issue in several Asian countries including India, China, Korea and ...
Cached Biology News:Solutions for a nitrogen-soaked world 2Powerful drug's surprising, simple method could lead to better treatments 2Powerful drug's surprising, simple method could lead to better treatments 3Female feticide in Canada requires action 2